APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor Concentrates

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Coagulation Factor Concentrates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173979000322 December 2025196 pages

Choose your research edition.

Industry ResearchCoagulation Factor Concentrates Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor Concentrates Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Coagulation Factor Concentrates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor Concentrates Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor Concentrates Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Coagulation Factor Concentrates market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Coagulation Factor Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coagulation Factor Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coagulation Factor Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Coagulation Factor Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coagulation Factor Concentrates include Bio Product Laboratory (UK), Biotest (Germany), CSL (Australia), Green Cross Corporation (South Korea), Grifols (Spain), Japan Blood Products Organization, China Biologic Products (China), Kedrion (Italy), LFB (France) and Octapharma (Switzerland), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Coagulation Factor Concentrates market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coagulation Factor Concentrates and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coagulation Factor Concentrates sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coagulation Factor Concentrates market size, projected growth trends, production technologies, key applications, and end-use industries.

Coagulation Factor Concentrates Segment by Company

Bio Product Laboratory (UK)

Biotest (Germany)

CSL (Australia)

Green Cross Corporation (South Korea)

Grifols (Spain)

Japan Blood Products Organization, China Biologic Products (China)

Kedrion (Italy)

LFB (France)

Octapharma (Switzerland)

Sanquin (Netherlands)

Shire (Ireland)

Shanghai RAAS Blood Products (China)

Coagulation Factor Concentrates Segment by Type

Factor XIII

Factor VIII

Factor IX

Fibrinogen Concentrates

Prothrombin Complex Concentrates

Von Willebrand Factor

Coagulation Factor Concentrates Segment by Application

Pulmonology

Rheumatology

Immunology

Neurology

Hematology

Hemato-Oncology

Critical Care

Others

Coagulation Factor Concentrates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor Concentrates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor Concentrates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor Concentrates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coagulation Factor Concentrates market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coagulation Factor Concentrates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Coagulation Factor Concentrates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Coagulation Factor Concentrates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Coagulation Factor Concentrates Industry Trends Table 2. Coagulation Factor Concentrates Industry Drivers Table 3. Coagulation Factor Concentrates Industry Opportunities and Challenges Table 4. Coagulation Factor Concentrates Industry Restraints Table 5. Global Coagulation Factor Concentrates Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Coagulation Factor Concentrates Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Coagulation Factor Concentrates Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Coagulation Factor Concentrates Sales Market Share by Manufacturers Table 9. Global Coagulation Factor Concentrates Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Coagulation Factor Concentrates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Coagulation Factor Concentrates Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Coagulation Factor Concentrates Manufacturers, Product Type & Application Table 13. Global Coagulation Factor Concentrates Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Coagulation Factor Concentrates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Factor XIII Table 17. Major Manufacturers of Factor VIII Table 18. Major Manufacturers of Factor IX Table 19. Major Manufacturers of Fibrinogen Concentrates Table 20. Major Manufacturers of Prothrombin Complex Concentrates Table 21. Major Manufacturers of Von Willebrand Factor Table 22. Global Coagulation Factor Concentrates Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Coagulation Factor Concentrates Sales by Type (2021-2026) & (k units) Table 24. Global Coagulation Factor Concentrates Sales by Type (2027-2032) & (k units) Table 25. Global Coagulation Factor Concentrates Sales Market Share by Type (2021-2026) Table 26. Global Coagulation Factor Concentrates Sales Market Share by Type (2027-2032) Table 27. Global Coagulation Factor Concentrates Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Coagulation Factor Concentrates Revenue by Type (2021-2026) & (k units) Table 29. Global Coagulation Factor Concentrates Revenue by Type (2027-2032) & (k units) Table 30. Global Coagulation Factor Concentrates Revenue Market Share by Type (2021-2026) Table 31. Global Coagulation Factor Concentrates Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Pulmonology Table 33. Major Manufacturers of Rheumatology Table 34. Major Manufacturers of Immunology Table 35. Major Manufacturers of Neurology Table 36. Major Manufacturers of Hematology Table 37. Major Manufacturers of Hemato-Oncology Table 38. Major Manufacturers of Critical Care Table 39. Major Manufacturers of Others Table 40. Global Coagulation Factor Concentrates Sales by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Coagulation Factor Concentrates Sales by Application (2021-2026) & (k units) Table 42. Global Coagulation Factor Concentrates Sales by Application (2027-2032) & (k units) Table 43. Global Coagulation Factor Concentrates Sales Market Share by Application (2021-2026) Table 44. Global Coagulation Factor Concentrates Sales Market Share by Application (2027-2032) Table 45. Global Coagulation Factor Concentrates Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 46. Global Coagulation Factor Concentrates Revenue by Application (2021-2026) & (k units) Table 47. Global Coagulation Factor Concentrates Revenue by Application (2027-2032) & (k units) Table 48. Global Coagulation Factor Concentrates Revenue Market Share by Application (2021-2026) Table 49. Global Coagulation Factor Concentrates Revenue Market Share by Application (2027-2032) Table 50. Global Coagulation Factor Concentrates Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 51. Global Coagulation Factor Concentrates Sales by Region (2021-2026) & (k units) Table 52. Global Coagulation Factor Concentrates Sales Market Share by Region (2021-2026) Table 53. Global Coagulation Factor Concentrates Sales Forecasted by Region (2027-2032) & (k units) Table 54. Global Coagulation Factor Concentrates Sales Forecasted Market Share by Region (2027-2032) Table 55. North America Coagulation Factor Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. North America Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 57. North America Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 58. Europe Coagulation Factor Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Europe Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 60. Europe Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 61. Asia Pacific Coagulation Factor Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 62. Asia Pacific Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 63. Asia Pacific Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 64. South America, Middle East and Africa Coagulation Factor Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 65. South America, Middle East and Africa Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 66. South America, Middle East and Africa Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 67. Global Coagulation Factor Concentrates Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Global Coagulation Factor Concentrates Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Coagulation Factor Concentrates Revenue by Region (2027-2032) & (US$ Million) Table 70. Global Coagulation Factor Concentrates Revenue Market Share by Region (2021-2026) Table 71. Global Coagulation Factor Concentrates Revenue Market Share by Region (2027-2032) Table 72. Bio Product Laboratory (UK) Company Information Table 73. Bio Product Laboratory (UK) Business Overview Table 74. Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio Table 76. Bio Product Laboratory (UK) Recent Development Table 77. Biotest (Germany) Company Information Table 78. Biotest (Germany) Business Overview Table 79. Biotest (Germany) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Biotest (Germany) Coagulation Factor Concentrates Product Portfolio Table 81. Biotest (Germany) Recent Development Table 82. CSL (Australia) Company Information Table 83. CSL (Australia) Business Overview Table 84. CSL (Australia) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. CSL (Australia) Coagulation Factor Concentrates Product Portfolio Table 86. CSL (Australia) Recent Development Table 87. Green Cross Corporation (South Korea) Company Information Table 88. Green Cross Corporation (South Korea) Business Overview Table 89. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio Table 91. Green Cross Corporation (South Korea) Recent Development Table 92. Grifols (Spain) Company Information Table 93. Grifols (Spain) Business Overview Table 94. Grifols (Spain) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Grifols (Spain) Coagulation Factor Concentrates Product Portfolio Table 96. Grifols (Spain) Recent Development Table 97. Japan Blood Products Organization, China Biologic Products (China) Company Information Table 98. Japan Blood Products Organization, China Biologic Products (China) Business Overview Table 99. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio Table 101. Japan Blood Products Organization, China Biologic Products (China) Recent Development Table 102. Kedrion (Italy) Company Information Table 103. Kedrion (Italy) Business Overview Table 104. Kedrion (Italy) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio Table 106. Kedrion (Italy) Recent Development Table 107. LFB (France) Company Information Table 108. LFB (France) Business Overview Table 109. LFB (France) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. LFB (France) Coagulation Factor Concentrates Product Portfolio Table 111. LFB (France) Recent Development Table 112. Octapharma (Switzerland) Company Information Table 113. Octapharma (Switzerland) Business Overview Table 114. Octapharma (Switzerland) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio Table 116. Octapharma (Switzerland) Recent Development Table 117. Sanquin (Netherlands) Company Information Table 118. Sanquin (Netherlands) Business Overview Table 119. Sanquin (Netherlands) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio Table 121. Sanquin (Netherlands) Recent Development Table 122. Shire (Ireland) Company Information Table 123. Shire (Ireland) Business Overview Table 124. Shire (Ireland) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Shire (Ireland) Coagulation Factor Concentrates Product Portfolio Table 126. Shire (Ireland) Recent Development Table 127. Shanghai RAAS Blood Products (China) Company Information Table 128. Shanghai RAAS Blood Products (China) Business Overview Table 129. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio Table 131. Shanghai RAAS Blood Products (China) Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Coagulation Factor Concentrates Distributors List Table 135. Coagulation Factor Concentrates Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Coagulation Factor Concentrates Product Image Figure 2. Global Coagulation Factor Concentrates Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor Concentrates Market Size (2021-2032) & (US$ Million) Figure 4. Global Coagulation Factor Concentrates Sales (2021-2032) & (k units) Figure 5. Global Coagulation Factor Concentrates Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Coagulation Factor Concentrates Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Factor XIII Image Figure 9. Factor VIII Image Figure 10. Factor IX Image Figure 11. Fibrinogen Concentrates Image Figure 12. Prothrombin Complex Concentrates Image Figure 13. Von Willebrand Factor Image Figure 14. Global Coagulation Factor Concentrates Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Coagulation Factor Concentrates Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Coagulation Factor Concentrates Sales Market Share by Type (2021-2032) Figure 17. Global Coagulation Factor Concentrates Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Coagulation Factor Concentrates Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Coagulation Factor Concentrates Revenue Market Share by Type (2021-2032) Figure 20. Pulmonology Image Figure 21. Rheumatology Image Figure 22. Immunology Image Figure 23. Neurology Image Figure 24. Hematology Image Figure 25. Hemato-Oncology Image Figure 26. Critical Care Image Figure 27. Others Image Figure 28. Global Coagulation Factor Concentrates Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 29. Global Coagulation Factor Concentrates Sales Market Share 2021 VS 2025 VS 2032 Figure 30. Global Coagulation Factor Concentrates Sales Market Share by Application (2021-2032) Figure 31. Global Coagulation Factor Concentrates Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Coagulation Factor Concentrates Revenue Market Share 2021 VS 2025 VS 2032 Figure 33. Global Coagulation Factor Concentrates Revenue Market Share by Application (2021-2032) Figure 34. North America Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 35. North America Coagulation Factor Concentrates Sales Market Share by Country (2021-2032) Figure 36. U.S. Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 37. Canada Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 38. Mexico Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 39. Europe Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 40. Europe Coagulation Factor Concentrates Sales Market Share by Country (2021-2032) Figure 41. Germany Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 42. France Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 43. U.K. Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 44. Italy Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 45. Netherlands Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 46. Asia Pacific Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 47. Asia Pacific Coagulation Factor Concentrates Sales Market Share by Country (2021-2032) Figure 48. China Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 49. Japan Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Korea Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 51. Southeast Asia Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 52. India Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 53. Australia Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 54. South America, Middle East and Africa Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 55. South America, Middle East and Africa Coagulation Factor Concentrates Sales Market Share by Country (2021-2032) Figure 56. Brazil Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 57. South Africa Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 58. Saudi Arabia Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 59. Turkey Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 60. Argentina Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 61. UAE Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 62. Egypt Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 63. Chile Coagulation Factor Concentrates Sales and Growth Rate (2021-2032) & (k units) Figure 64. Global Coagulation Factor Concentrates Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 65. Global Coagulation Factor Concentrates Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 66. North America Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Figure 67. North America Coagulation Factor Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Europe Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Figure 69. Europe Coagulation Factor Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Asia-Pacific Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Figure 71. Asia-Pacific Coagulation Factor Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. South America, Middle East and Africa Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Figure 73. South America, Middle East and Africa Coagulation Factor Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 74. Coagulation Factor Concentrates Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Coagulation Factor Concentrates Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Factor XIII
  • Factor VIII
  • Factor IX
  • Fibrinogen Concentrates
  • Prothrombin Complex Concentrates
  • Von Willebrand Factor
Applications
  • Pulmonology
  • Rheumatology
  • Immunology
  • Neurology
  • Hematology
  • Hemato-Oncology
  • Critical Care
  • Others
Companies covered
  • Bio Product Laboratory (UK)
  • Biotest (Germany)
  • CSL (Australia)
  • Green Cross Corporation (South Korea)
  • Grifols (Spain)
  • Japan Blood Products Organization, China Biologic Products (China)
  • Kedrion (Italy)
  • LFB (France)
  • Octapharma (Switzerland)
  • Sanquin (Netherlands)
  • Shire (Ireland)
  • Shanghai RAAS Blood Products (China)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Coagulation Factor Concentrates Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Coagulation Factor Concentrates Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Coagulation Factor Concentrates Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Coagulation Factor Concentrates Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Coagulation Factor Concentrates Market Dynamics
  1. 2.1 Coagulation Factor Concentrates Industry Trends
  2. 2.2 Coagulation Factor Concentrates Industry Drivers
  3. 2.3 Coagulation Factor Concentrates Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor Concentrates Industry Restraints
3 Coagulation Factor Concentrates Market by Manufacturers
  1. 3.1 Global Coagulation Factor Concentrates Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Coagulation Factor Concentrates Sales by Manufacturers (2021-2026)
  3. 3.3 Global Coagulation Factor Concentrates Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Coagulation Factor Concentrates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coagulation Factor Concentrates Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Coagulation Factor Concentrates Manufacturers, Product Type & Application
  7. 3.7 Global Coagulation Factor Concentrates Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coagulation Factor Concentrates Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coagulation Factor Concentrates Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coagulation Factor Concentrates Tier 1, Tier 2, and Tier 3
4 Coagulation Factor Concentrates Market by Type
  1. 4.1 Coagulation Factor Concentrates Type Introduction
  2. 4.1.1 Factor XIII
  3. 4.1.2 Factor VIII
  4. 4.1.3 Factor IX
  5. 4.1.4 Fibrinogen Concentrates
  6. 4.1.5 Prothrombin Complex Concentrates
  7. 4.1.6 Von Willebrand Factor
  8. 4.2 Global Coagulation Factor Concentrates Sales by Type
  9. 4.2.1 Global Coagulation Factor Concentrates Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Coagulation Factor Concentrates Sales by Type (2021-2032)
  11. 4.2.3 Global Coagulation Factor Concentrates Sales Market Share by Type (2021-2032)
  12. 4.3 Global Coagulation Factor Concentrates Revenue by Type
  13. 4.3.1 Global Coagulation Factor Concentrates Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Coagulation Factor Concentrates Revenue by Type (2021-2032)
  15. 4.3.3 Global Coagulation Factor Concentrates Revenue Market Share by Type (2021-2032)
5 Coagulation Factor Concentrates Market by Application
  1. 5.1 Coagulation Factor Concentrates Application Introduction
  2. 5.1.1 Pulmonology
  3. 5.1.2 Rheumatology
  4. 5.1.3 Immunology
  5. 5.1.4 Neurology
  6. 5.1.5 Hematology
  7. 5.1.6 Hemato-Oncology
  8. 5.1.7 Critical Care
  9. 5.1.8 Others
  10. 5.2 Global Coagulation Factor Concentrates Sales by Application
  11. 5.2.1 Global Coagulation Factor Concentrates Sales by Application (2021 VS 2025 VS 2032)
  12. 5.2.2 Global Coagulation Factor Concentrates Sales by Application (2021-2032)
  13. 5.2.3 Global Coagulation Factor Concentrates Sales Market Share by Application (2021-2032)
  14. 5.3 Global Coagulation Factor Concentrates Revenue by Application
  15. 5.3.1 Global Coagulation Factor Concentrates Revenue by Application (2021 VS 2025 VS 2032)
  16. 5.3.2 Global Coagulation Factor Concentrates Revenue by Application (2021-2032)
  17. 5.3.3 Global Coagulation Factor Concentrates Revenue Market Share by Application (2021-2032)
6 Global Coagulation Factor Concentrates Sales by Region
  1. 6.1 Global Coagulation Factor Concentrates Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coagulation Factor Concentrates Sales by Region (2021-2032)
  3. 6.2.1 Global Coagulation Factor Concentrates Sales by Region (2021-2026)
  4. 6.2.2 Global Coagulation Factor Concentrates Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Coagulation Factor Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Coagulation Factor Concentrates Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Coagulation Factor Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Coagulation Factor Concentrates Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Coagulation Factor Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Coagulation Factor Concentrates Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Coagulation Factor Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Coagulation Factor Concentrates Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Coagulation Factor Concentrates Revenue by Region
  1. 7.1 Global Coagulation Factor Concentrates Revenue by Region
  2. 7.1.1 Global Coagulation Factor Concentrates Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Coagulation Factor Concentrates Revenue by Region (2021-2026)
  4. 7.1.3 Global Coagulation Factor Concentrates Revenue by Region (2027-2032)
  5. 7.1.4 Global Coagulation Factor Concentrates Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Coagulation Factor Concentrates Revenue (2021-2032)
  8. 7.2.2 North America Coagulation Factor Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Coagulation Factor Concentrates Revenue (2021-2032)
  11. 7.3.2 Europe Coagulation Factor Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Coagulation Factor Concentrates Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Coagulation Factor Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Coagulation Factor Concentrates Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Coagulation Factor Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bio Product Laboratory (UK)
  2. 8.1.1 Bio Product Laboratory (UK) Company Information
  3. 8.1.2 Bio Product Laboratory (UK) Business Overview
  4. 8.1.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio
  6. 8.1.5 Bio Product Laboratory (UK) Recent Developments
  7. 8.2 Biotest (Germany)
  8. 8.2.1 Biotest (Germany) Company Information
  9. 8.2.2 Biotest (Germany) Business Overview
  10. 8.2.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biotest (Germany) Coagulation Factor Concentrates Product Portfolio
  12. 8.2.5 Biotest (Germany) Recent Developments
  13. 8.3 CSL (Australia)
  14. 8.3.1 CSL (Australia) Company Information
  15. 8.3.2 CSL (Australia) Business Overview
  16. 8.3.3 CSL (Australia) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CSL (Australia) Coagulation Factor Concentrates Product Portfolio
  18. 8.3.5 CSL (Australia) Recent Developments
  19. 8.4 Green Cross Corporation (South Korea)
  20. 8.4.1 Green Cross Corporation (South Korea) Company Information
  21. 8.4.2 Green Cross Corporation (South Korea) Business Overview
  22. 8.4.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio
  24. 8.4.5 Green Cross Corporation (South Korea) Recent Developments
  25. 8.5 Grifols (Spain)
  26. 8.5.1 Grifols (Spain) Company Information
  27. 8.5.2 Grifols (Spain) Business Overview
  28. 8.5.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Grifols (Spain) Coagulation Factor Concentrates Product Portfolio
  30. 8.5.5 Grifols (Spain) Recent Developments
  31. 8.6 Japan Blood Products Organization, China Biologic Products (China)
  32. 8.6.1 Japan Blood Products Organization, China Biologic Products (China) Company Information
  33. 8.6.2 Japan Blood Products Organization, China Biologic Products (China) Business Overview
  34. 8.6.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio
  36. 8.6.5 Japan Blood Products Organization, China Biologic Products (China) Recent Developments
  37. 8.7 Kedrion (Italy)
  38. 8.7.1 Kedrion (Italy) Company Information
  39. 8.7.2 Kedrion (Italy) Business Overview
  40. 8.7.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio
  42. 8.7.5 Kedrion (Italy) Recent Developments
  43. 8.8 LFB (France)
  44. 8.8.1 LFB (France) Company Information
  45. 8.8.2 LFB (France) Business Overview
  46. 8.8.3 LFB (France) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LFB (France) Coagulation Factor Concentrates Product Portfolio
  48. 8.8.5 LFB (France) Recent Developments
  49. 8.9 Octapharma (Switzerland)
  50. 8.9.1 Octapharma (Switzerland) Company Information
  51. 8.9.2 Octapharma (Switzerland) Business Overview
  52. 8.9.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio
  54. 8.9.5 Octapharma (Switzerland) Recent Developments
  55. 8.10 Sanquin (Netherlands)
  56. 8.10.1 Sanquin (Netherlands) Company Information
  57. 8.10.2 Sanquin (Netherlands) Business Overview
  58. 8.10.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio
  60. 8.10.5 Sanquin (Netherlands) Recent Developments
  61. 8.11 Shire (Ireland)
  62. 8.11.1 Shire (Ireland) Company Information
  63. 8.11.2 Shire (Ireland) Business Overview
  64. 8.11.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shire (Ireland) Coagulation Factor Concentrates Product Portfolio
  66. 8.11.5 Shire (Ireland) Recent Developments
  67. 8.12 Shanghai RAAS Blood Products (China)
  68. 8.12.1 Shanghai RAAS Blood Products (China) Company Information
  69. 8.12.2 Shanghai RAAS Blood Products (China) Business Overview
  70. 8.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio
  72. 8.12.5 Shanghai RAAS Blood Products (China) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coagulation Factor Concentrates Value Chain Analysis
  2. 9.1.1 Coagulation Factor Concentrates Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coagulation Factor Concentrates Production Mode & Process
  6. 9.2 Coagulation Factor Concentrates Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coagulation Factor Concentrates Distributors
  9. 9.2.3 Coagulation Factor Concentrates Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst